Syros Pharmaceuticals Inc (SYRS)
6.00
+0.20
(+3.45%)
USD |
NASDAQ |
Jun 14, 16:00
6.00
0.00 (0.00%)
After-Hours: 20:00
Syros Pharmaceuticals Accounts Payable (Quarterly): 11.35M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 11.35M |
December 31, 2023 | 11.54M |
September 30, 2023 | 2.855M |
June 30, 2023 | 6.693M |
March 31, 2023 | 2.795M |
December 31, 2022 | 6.411M |
September 30, 2022 | 13.02M |
June 30, 2022 | 6.124M |
March 31, 2022 | 2.841M |
December 31, 2021 | 3.692M |
September 30, 2021 | 4.108M |
June 30, 2021 | 3.671M |
March 31, 2021 | 3.66M |
December 31, 2020 | 3.603M |
September 30, 2020 | 4.94M |
June 30, 2020 | 2.803M |
March 31, 2020 | 4.636M |
Date | Value |
---|---|
December 31, 2019 | 5.853M |
September 30, 2019 | 8.043M |
June 30, 2019 | 1.759M |
March 31, 2019 | 2.632M |
December 31, 2018 | 3.309M |
September 30, 2018 | 2.671M |
June 30, 2018 | 1.263M |
March 31, 2018 | 1.717M |
December 31, 2017 | 2.283M |
September 30, 2017 | 1.846M |
June 30, 2017 | 1.348M |
March 31, 2017 | 2.377M |
December 31, 2016 | 2.415M |
September 30, 2016 | 4.039M |
June 30, 2016 | 1.645M |
March 31, 2016 | 2.26M |
December 31, 2015 | 5.035M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
1.759M
Minimum
Jun 2019
13.02M
Maximum
Sep 2022
5.520M
Average
4.372M
Median
Accounts Payable (Quarterly) Benchmarks
PDS Biotechnology Corp | 6.001M |
PAVmed Inc | 1.485M |
Moderna Inc | 183.00M |
Altimmune Inc | 3.76M |
iBio Inc | 1.228M |